top of page

RESOURCES

Selected publications

The science is documented in the peer-reviewed literature and a substantial patent record.

2025

Deaminase Modulation Driving a New Era in Drug Development

Lindley, R.A. International Journal of Molecular Sciences, 26(23), 11532.

2021

Predicting clinical outcomes using cancer progression associated signatures

Mamrot, J.; Hall, N.E.; Lindley, R.A. Oncatarget, 12(8), 845-858.

2016

Association between targeted somatic mutation (TSM) signatures and HGS-OvCa progression

Lindley, R.A. et al. Cancer Medicine. 95% sensitivity, 90% specificity (n=194).

Patents

Four patent families across somatic-mutagenesis cause, recurrence detection, therapy-efficacy prediction and progression prediction

Granted and validated across 11 national jurisdictions with European Patent coverage.

Further publications and a media section are in preparation.

bottom of page